247148 Determining a way to measure the level of stigma associated with hepatitis B in Asian and Pacific Islander communities

Tuesday, November 1, 2011: 10:50 AM

Daniel Chu , Center for the Study of Asian American Health, New York University B Free CEED, New York
Isha Weerasinghe, MSc , Center for the Study of Asian American Health, New York University School of Medicine, New York, NY
Simona Kwon, DrPH, MPH , Center for the Study of Asian American Health, New York University School of Medicine, New York, NY
Kay Chun, MD , Public Health & Research Center, Korean Community Services, New York, NY
Shao-Chee Sim, PhD , Charles B. Wang Community Health Center, New York, NY
Background: Chronic hepatitis B (CHB) remains a significantly prevalent disease condition among Asians and Pacific Islanders (API), affecting as much as 10-15% of APIs nationally. Most affected are immigrants from East and Southeast Asia, where CHB education and testing and vaccination rates are low. Current efforts seek to reduce the impact of CHB and the spread of hepatitis B among APIs however these efforts are potentially hampered by stigma associated with a chronic infection and carrier status. Objective/purpose: Hepatitis B-related stigma can be attributed to the stigma-related practices, norms, and experiences from API immigrants' countries of origin; these constructs are carried over and continued in the US. Currently, the stigma associated with hepatitis B has not been significantly researched and few measures quantify the level of stigma communities face. Hepatitis B-related stigma presents a potential barrier to health intervention efforts. This warrants increased attention and additional study. Methods: A literature review was conducted on hepatitis B-related stigma and discrimination. Results: Based on the findings, a brief survey scale was created to assess hepatitis B stigma. Question items were adapted from stigma scales for other health conditions. Discussion: The paucity of past research resulted in difficulty in generating a comprehensive survey scale, confirming the need for additional study. The survey was piloted with a Vietnamese community sample in New York City. Demographics of the Vietnamese population surveyed and the results of the stigma questions will be presented.

Learning Areas:
Public health or related research
Social and behavioral sciences
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Discuss the association between hepatitis B and stigma. Analyze the health disparities and contextual factors behind stigma and hepatitis B in API communities.

Keywords: Hepatitis B, Immigrants

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I supervised Daniel (the lead author) on his research of the HBV stigma scale.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.